InsidersTradesSigma
Track the 선바이오 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 선바이오 has logged 4 public disclosures. Market capitalisation: €78.7bn. The latest transaction was reported on 9 June 2026 (Purchase). Among the most active insiders: 노광. The full history is accessible without an account.
4
Insider Decl.
n/a
Thresholds
€72,519
4 ops.
Buy Volume
n/a
n/a
Sell Volume
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,918 of 29,064 companies
56.5
score / 100
Value43
Quality70
FCF yld0.8%
Earn yld3.8%
EV/EBITDA17.3x
ROE35%
Gross mgn61%
Net mgn20%
Debt/EBITDA4.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 June 2026
Declarations4 total
4 of 4 declarations
Acerca de 선바이오
선바이오 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones biofarmacéuticas.